Kurzawski Grzegorz
International Hereditary Cancer Center, Department of Genetics and Pathology, Szczecin, Poland.
Hered Cancer Clin Pract. 2006 Dec 15;4(4):197-205. doi: 10.1186/1897-4287-4-4-197.
This manuscript is composed of five parts which summarize five publications in succession. Essentially, they are concerned with molecular diagnostics of Lynch syndrome and are based on studies in 238 families. The finding that young age at diagnosis is the key feature in patients with MSH2 and MLH1 mutations (Part 1) has helped to define simple criteria for the preliminary diagnosis of this syndrome. A cheaper method for the detection of mutations has been developed (Part 2) and applied to study the types of mutations and their prevalence in Poland (Part 3) and the Baltic States (Part 4). A specific feature of these mutations, i.e. presence of recurrent mutations in the majority of affected families with mutations, has suggested the feasibility of effective diagnostics with a single test disclosing all of them. An attempt to reveal other causes of familial aggregation of colorectal cancer has ruled out any association with C insertion in the NOD2 gene (Part 5).
本手稿由五个部分组成,依次总结了五篇出版物。从本质上讲,它们涉及林奇综合征的分子诊断,并基于对238个家庭的研究。诊断时年龄较轻是MSH2和MLH1突变患者的关键特征这一发现(第1部分)有助于确定该综合征初步诊断的简单标准。已开发出一种更便宜的突变检测方法(第2部分),并应用于研究波兰(第3部分)和波罗的海国家(第4部分)的突变类型及其患病率。这些突变的一个特定特征,即在大多数有突变的受影响家庭中存在复发性突变,表明通过一次检测揭示所有突变进行有效诊断的可行性。揭示结直肠癌家族聚集其他原因的尝试排除了与NOD2基因中C插入的任何关联(第5部分)。